You are requesting access for information not intended for your determined location. Do you want to continue to this page?

Or, use the
to visit a different site

Remember this location

You are about to exit for another SJM country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

The website you have requested also may not be optimized for your specific screen size.

MRI Ready

This device is commercially available for use in select international markets.

Treat More Patients With Better Results1

St. Jude Medical offers the only neuromodulation system approved to stimulate a cluster of nerves called the dorsal root ganglion (or DRG). DRG stimulation expands the range of neurostimulation options you can offer, and allows you to treat patients with focal chronic intractable pain in specific anatomical locations such as the foot, knee, hip and groin.

The Proclaim DRG IPG offers patients advanced features for convenience and comfort, so they can stay focused on their lives and not their therapy.

Longer Battery Life*,2,3

The Proclaim DRG IPG neurostimulator features a battery life of 6.5 years at nominal settings, potentially reducing the number of procedures and replacement devices, and increasing the time between battery replacements.

Upgradability

Upgradable technology—only from St. Jude Medical—allows patients to benefit from our next advancement in chronic pain therapy without surgery. Patients will receive advances easily and painlessly through a simple software upgrade upon market approval.

The Proclaim DRG IPG neurostimulator is MR Conditional, allowing scans of the head and extremities within approved MRI parameters.

Expanding the Treatable Patient Population

The Proclaim™ DRG IPG neurostimulator system is part of our spinal cord stimulation (SCS) portfolio. Our vision is to transform the management of chronic pain by expanding the range of neurostimulation options available and setting a new standard of care to help improve the lives of more patients. Read more about the portfolio and our approach to chronic pain management.

Unless otherwise noted, ™ indicates that the name is a trademark of, or licensed to, St. Jude Medical or one of its subsidiaries.
ST. JUDE MEDICAL and the nine-squares symbol are trademarks and service marks of St. Jude Medical, LLC and its related companies.

‡ Trademarks, including logos, and service marks marked with a ‡ indicates that the trademark is a registered or unregistered third party trademark and the property of its respective owner. See Terms and Conditions.‬‬‬